Es gab 50 kürzliche Insider-Transaktionen für Citius Pharmaceuticals, Inc. (CTXR), darunter 37 Käufe und 10 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $5.54M und die gesamten Insider-Verkäufe auf $11.12M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Holubiak Myron Z, Mazur Leonard L, Mcgrath Dennis M. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — CTXR
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2025-08-08 |
Holubiak Myron Z |
Vice Chairman |
Aktienrückgabe |
31,373 |
$28.75 |
$901.97K |
- |
| 2025-08-08 |
Mazur Leonard L |
Chief Executive Officer |
Aktienrückgabe |
89,388 |
$19.25 |
$1.72M |
- |
| 2024-11-07 |
Holubiak Myron Z |
Vice Chairman |
RSU-Zuteilung |
75,000 |
$0.38 |
$28.5K |
75,000 |
| 2024-11-07 |
Mcgrath Dennis M |
Director |
RSU-Zuteilung |
125,000 |
$0.38 |
$47.5K |
125,000 |
| 2024-11-07 |
Mazur Leonard L |
10 Percent Owner, Officer: Chief Executive Officer |
RSU-Zuteilung |
600,000 |
$0.38 |
$228K |
600,000 |
| 2024-11-07 |
Dutia Suren G |
Director |
RSU-Zuteilung |
125,000 |
$0.38 |
$47.5K |
125,000 |
| 2024-11-07 |
Webb Carol |
Director |
RSU-Zuteilung |
125,000 |
$0.38 |
$47.5K |
125,000 |
| 2024-11-07 |
Holuka Eugene Myron |
Director |
RSU-Zuteilung |
125,000 |
$0.38 |
$47.5K |
125,000 |
| 2024-11-07 |
Bartushak Jaime |
Chief Financial Officer |
RSU-Zuteilung |
350,000 |
$0.38 |
$133K |
350,000 |
| 2024-11-07 |
Czuczman Myron |
Chief Medical Officer |
RSU-Zuteilung |
300,000 |
$0.38 |
$114K |
300,000 |
| 2024-11-07 |
Smith Robert Joseph |
Director |
RSU-Zuteilung |
125,000 |
$0.38 |
$47.5K |
125,000 |
| 2024-09-25 |
Holubiak Myron Z |
Vice Chairman |
Aktienrückgabe |
558,597 |
$0.77 |
$430.12K |
- |
| 2024-09-25 |
Mazur Leonard L |
10 Percent Owner, Officer: Chief Executive Officer |
Aktienrückgabe |
2,234,700 |
$0.77 |
$1.72M |
- |
| 2024-08-14 |
Holubiak Myron Z |
Vice Chairman |
Aktienrückgabe |
784,314 |
$1.15 |
$901.96K |
- |
| 2024-08-14 |
Mazur Leonard L |
10 Percent Owner, Officer: Chief Executive Officer |
Aktienrückgabe |
3,137,255 |
$1.15 |
$3.61M |
- |
| 2024-04-03 |
Holubiak Myron Z |
Vice Chairman |
Aktienrückgabe |
129,450 |
$1.42 |
$183.82K |
- |
| 2024-04-03 |
Mazur Leonard L |
10 Percent Owner, Officer: Chief Executive Officer |
Aktienrückgabe |
1,165,048 |
$1.42 |
$1.65M |
- |
| 2024-03-14 |
Smith Robert Joseph |
Director |
RSU-Zuteilung |
75,000 |
$0.69 |
$51.75K |
75,000 |
| 2024-03-13 |
Holuka Eugene Myron |
Director |
Optionsausübung (Verkauf) |
2,415 |
$0.02 |
$36.23 |
- |
| 2024-03-12 |
Smith Robert Joseph |
Director |
Unbekannt |
- |
- |
- |
- |
| 2024-03-04 |
Webb Carol |
Director |
Optionsausübung (Verkauf) |
12,071 |
$0.02 |
$181.07 |
- |
| 2023-10-10 |
Holubiak Myron Z |
Vice Chairman |
RSU-Zuteilung |
400,000 |
$0.70 |
$280K |
400,000 |
| 2023-10-10 |
Mcgrath Dennis M |
Director |
RSU-Zuteilung |
75,000 |
$0.70 |
$52.5K |
75,000 |
| 2023-10-10 |
Mazur Leonard L |
10 Percent Owner, Officer: Chief Executive Officer |
RSU-Zuteilung |
550,000 |
$0.70 |
$385K |
550,000 |
| 2023-10-10 |
Dutia Suren G |
Director |
RSU-Zuteilung |
75,000 |
$0.70 |
$52.5K |
75,000 |
| 2023-10-10 |
Webb Carol |
Director |
RSU-Zuteilung |
75,000 |
$0.70 |
$52.5K |
75,000 |
| 2023-10-10 |
Holuka Eugene Myron |
Director |
RSU-Zuteilung |
75,000 |
$0.70 |
$52.5K |
75,000 |
| 2023-10-10 |
Bartushak Jaime |
Chief Financial Officer |
RSU-Zuteilung |
300,000 |
$0.70 |
$210K |
300,000 |
| 2023-10-10 |
Czuczman Myron |
Chief Medical Officer |
RSU-Zuteilung |
300,000 |
$0.70 |
$210K |
300,000 |
| 2023-02-07 |
Mcgrath Dennis M |
Director |
Unbekannt |
- |
- |
- |
- |
| 2023-02-07 |
Mcgrath Dennis M |
Director |
RSU-Zuteilung |
75,000 |
$1.42 |
$106.5K |
75,000 |
| 2022-10-04 |
Holubiak Myron Z |
Vice Chairman |
RSU-Zuteilung |
400,000 |
- |
- |
400,000 |
| 2022-10-04 |
Safir Howard |
Director |
RSU-Zuteilung |
75,000 |
- |
- |
75,000 |
| 2022-10-04 |
Mazur Leonard L |
Executive Chairman |
RSU-Zuteilung |
550,000 |
- |
- |
550,000 |
| 2022-10-04 |
Dutia Suren G |
Director |
RSU-Zuteilung |
75,000 |
- |
- |
75,000 |
| 2022-10-04 |
Webb Carol |
Director |
RSU-Zuteilung |
75,000 |
- |
- |
75,000 |
| 2022-10-04 |
Kane William |
Director |
RSU-Zuteilung |
75,000 |
- |
- |
75,000 |
| 2022-10-04 |
Holuka Eugene Myron |
Director |
RSU-Zuteilung |
75,000 |
- |
- |
75,000 |
| 2022-10-04 |
Bartushak Jaime |
Chief Financial Officer |
RSU-Zuteilung |
300,000 |
- |
- |
300,000 |
| 2022-10-04 |
Czuczman Myron |
Chief Medical Officer |
RSU-Zuteilung |
300,000 |
- |
- |
300,000 |
| 2022-10-04 |
Mazur Leonard L |
10 Percent Owner, Officer: Executive Chairman |
Unbekannt |
- |
- |
- |
- |
| 2021-10-11 |
Holubiak Myron Z |
President and CEO |
RSU-Zuteilung |
15,000 |
$2.04 |
$30.6K |
15,000 |
| 2021-10-11 |
Safir Howard |
Director |
RSU-Zuteilung |
75,000 |
$2.04 |
$153K |
75,000 |
| 2021-10-11 |
Mazur Leonard L |
10 Percent Owner, Officer: Executive Chairman |
RSU-Zuteilung |
650,000 |
$2.04 |
$1.33M |
650,000 |
| 2021-10-11 |
Dutia Suren G |
Director |
RSU-Zuteilung |
75,000 |
$2.04 |
$153K |
75,000 |
| 2021-10-11 |
Webb Carol |
Director |
RSU-Zuteilung |
75,000 |
$2.04 |
$153K |
75,000 |
| 2021-10-11 |
Kane William |
Director |
RSU-Zuteilung |
75,000 |
$2.04 |
$153K |
75,000 |
| 2021-10-11 |
Holuka Eugene Myron |
Director |
RSU-Zuteilung |
75,000 |
$2.04 |
$153K |
75,000 |
| 2021-10-11 |
Bartushak Jaime |
Chief Financial Officer |
RSU-Zuteilung |
300,000 |
$2.04 |
$612K |
300,000 |
| 2021-10-11 |
Czuczman Myron |
Chief Medical Officer |
RSU-Zuteilung |
300,000 |
$2.04 |
$612K |
300,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
